Novavax | Dochód Netto





Dochód Netto Zmiana Data
Adma Biologics USD 36.43M 2.21M 2025-09
Agenus USD -25.27M 20.59M 2025-03
AstraZeneca USD 2.33B 207M 2025-12
BioCryst Pharmaceuticals USD -88.88M 74.85M 2024-12
Cassava Sciences USD -10.81M 33.41M 2025-09
Geron USD -31.14M 12.72M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
MannKind USD -15.95M 23.93M 2025-12
Merck USD 2.96B 2.82B 2025-12
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Moderna USD -200M 625M 2025-09
Novartis USD 3.93B 113M 2025-09
Novavax USD -121.3M 283.68M 2024-09
Pfizer USD -1.65B 5.19B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
TG Therapeutics USD 23.04M 367.86M 2025-12


Novavax Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2026.